Celanese posts Q3 2026 results, raises 2027 free cash flow outlook

Celanese Corp reported third‑quarter 2026 revenue of $2.56 billion and adjusted earnings of $1.65 per share, beating consensus. The quarter generated $461 million of free cash flow and the company announced a 19% stake sale in its Nutrinova joint venture for about $152 million, expected to close in Q4 2026. Management guided to $700 million‑$800 million of free cash flow in 2027 and said it will achieve $100 million of cost and interest savings, with restructuring costs falling $30 million‑$40 million that year.

The higher free‑cash‑flow target and cost‑saving plan could increase cash available for debt reduction, dividends or reinvestment, according to management’s comments. The stake sale provides an immediate cash infusion of roughly $152 million.

  • 1Q3 2026 revenue was $2.56 billion, below estimates.
  • 2Adjusted earnings per share were $1.65, beating the $1.56 consensus.
  • 3Free cash flow for the quarter was $461 million.
  • 4Celanese announced a 19% stake sale in the Nutrinova joint venture for approximately $152 million, expected to close in Q4 2026.
  • 5Management expects 2027 free cash flow of $700 million to $800 million.
  • 6The company targets $100 million of cost and interest savings in 2027.

Sources